Monday

28th May 2018

Analysis

'Think of the patients!' cry EU agency contenders

  • The EMA evaluates if medicines are safe (Photo: Grumpy-Puddin)

Does the future home of the European Medicines Agency matter to patient safety?

The cry '...but think of the children!' has often been used seriously in politics - but also satirically, in TV series like the Simpsons.

Dear EUobserver reader

Subscribe now for unrestricted access to EUobserver.

Sign up for 30 days' free trial, no obligation. Full subscription only 15 € / month or 150 € / year.

  1. Unlimited access on desktop and mobile
  2. All premium articles, analysis, commentary and investigations
  3. EUobserver archives

EUobserver is the only independent news media covering EU affairs in Brussels and all 28 member states.

♡ We value your support.

If you already have an account click here to login.

  • Will patients be at risk if the 'wrong' city is chosen to host EMA? (Photo: Helena Spongenberg)

Now, a variation on the theme has been used in earnest in the past few months by European ministers, in the debate about which city is best equipped to host the London-based European Medicines Agency (EMA).

The EMA has to find a new home after Brexit, and nineteen member states have offered to host it.

"Ladies and gentlemen, millions of Europeans depend on the availability of high-quality, effective, safe medicine," said Dutch health minister Edith Schippers last July, when promoting the bid for Amsterdam.

"Think of the many people with chronic diseases, who can live good and productive lives thanks to their medication," she said.

"Think of all those patients with cancer that have an ever-increasing chance of survival, thanks to innovative treatments and medication. The same is true for people with rare diseases. They are looking at us politicians. Can we ensure their access to the treatments they need?"

Spanish health minister Dolors Montserrat said the same thing, when she came to Brussels in May to argue why Barcelona was "the best city" to host the EMA.

She also referred to the argument - made by some EU member states that currently do not host any EU agency - that the offices should be distributed evenly.

Montserrat told EUobserver that whether a member state already has an agency should not be relevant to the decision on where to relocate EMA.

"We have to think of the health of the European patients," she said, noting that some candidate cities "perhaps" did not have the best infrastructure, international schools, or an airport with frequent flights to European capitals.

"So we have to save the health of the European citizens. .. We have to do a smooth relocation," she said.

Unspoken criticism

The phrase 'smooth relocation' has been uttered by most of Montserrat's counterparts from the other competing member states in the past half year.

The unspoken accusation in the words of these health ministers is of course that a relocation to the city of some of the candidates would lead to a potential health risk, maybe even leading to deaths.

So is there such a risk?

Smooth relocation

The EMA is responsible for evaluating the safety of medicines for humans as well as for other animals.

As of last week, the EMA had given 75 positive opinions on new medicines this year, and five negative opinions.

Belgian health minister Maggie De Block told EUobserver earlier this month that there should be no "disruptive effect" during the agency's move from London to the new host city.

"Otherwise this would mean that patients will have access to new medication later than normal," she said. "So for some people that medication will arrive too late. That would be a disaster."

However, De Block would not say if any of the candidate countries, if selected, would lead to such a disastrous scenario.

"We keep it fair," she said. "May the best [candidate] win."

Helsinki mayor Jan Vapaavuori, promoting his city's bid, also declined to answer.

"You asked about the worst case scenario. We do not comment [on] that. We only know what's the best case scenario," he said.

Clinical trials

Health minister Konstanty Radziwill did make an allusion to countries who do not fit the criteria, albeit indirectly.

Radziwill noted in an interview with EUobserver that in Poland between 30,000 and 40,000 citizens are involved in clinical trials annually.

"We have a population of 38 million. If the population is much, much smaller, this is impossible," he said.

But according to a health expert from one of the countries with the smallest populations in the race to host the EMA, that argument is invalid.

"The number of individuals included in clinical trials in the host country has no relevance for the relocation of the EMA," said Sinisa Tomic, head of the Croatian medicines agency.

Croatia has a population of 4.2 million. Its capital Zagreb is a candidate.

"Companies perform clinical trials all over the world and bring their results to the EMA in order to obtain approval for their medicinal products," Tomic told EUobserver via email.

The authorisation of clinical trials takes place at the national level, not the EU level.

Some member states had hoped that the European Commission would make a shortlist, or at least some ranking of the different bids.

However, its assessment of the bids, published last month, was extremely factual.

For example, in the commission's discussion of the criterion "business continuity", the EU's executive refrained from giving a value judgement, or any fact-checking of statements made.

Risk of 'permanent damage'

But the European Medicines Agency itself was much more direct.

Days after the commission had presented its document, the EMA published an assessment of the bids, which did include preferences, and criteria.

It also warned that many staff members were considering leaving the agency, depending on the city chosen.

In the best case scenario – a choice for Amsterdam, Barcelona, Copenhagen, Milan, or Vienna – between 19 percent and 35 percent of staff said they would "likely" or "very likely" quit.

This would lead to the approval of new medicines being "largely maintained", EMA said, although it noted there would still be the "possibility of delays". The agency would then need between two and three years to fully recover from the move.

But if EMA would move to Athens, Bratislava, Bucharest, Helsinki, Malta, Sofia, Warsaw, or Zagreb, between 72 and 94 percent of staff said they would probably leave the agency.

If that were to happen, this would lead to "permanent damage to the system" and an "unravelling of the EU single market for medicines". In that scenario, EMA expects some medicines to become unavailable and a need to import from outside the EU, mainly Japan and the US.

Moreover, in that scenario, EMA expected patients to be "exposed to side effects – deaths – litigation".

Of course, what EMA staff said in the survey they would do, is not necessarily what they will actually do.

Once a decision has been made for a city, personnel will probably make another weighing: do I really want to quit my job, or can I still have a good life in this new city?

The conundrum is that there is no scientific method to determine how many staff will actually leave – the real staff loss will not be known until a city has been chosen, when it will be too late for a minister to change their mind.

On Tuesday (17 October), interior and EU affairs ministers will discuss the bids at a meeting in Luxembourg.

It is unlikely a decision will be made this week.

Rather, it is expected that the next ministerial meeting of that format, now scheduled for 20 November, will see up to three rounds of voting to determine the new seat of the EMA.

Read more on EU agencies in EUobserver's 2017 Regions & Cities Magazine.

Click here to access EUobserver's entire magazine collection.

EU medicines agency reveals new home preferences

Staff said they preferred to move to Amsterdam, Barcelona, Copenhagen, Milan, or Vienna. More than 70% said they would quit if the agency moved to Athens, Bratislava, Bucharest, Helsinki, Malta, Sofia, Warsaw, or Zagreb.

Magazine

The EU Agencies Race

In this edition of EUobserver's Regions & Cities magazine, we take a closer look at some of the EU agencies, exploring how their location matters and the benefits for cities and regions to host them.

EU agency bids assessment brings 'nothing new'

The commission said it did not have time to look beyond the documents each of the contending member states sent to the Council of the EU, which were already public.

Leaders lobby on EU agencies in summit margins

The official agenda point on where to relocate the EU medicines and banking agencies after Brexit was over in "one minute", but lobbying took place in the corridors.

Feature

Nordic scientists warn Brussels over 'superbugs'

Superbugs already kill 25,000 Europeans each year, despite hospitals fighting to stop the antibiotic resistant bacteria from spreading. This week the Nordic Council lobbied Brussels to wake up.

Supported by

Stakeholders' Highlights

  1. Counter BalanceEuropean Ombudsman requests more lending transparency from European Investment Bank
  2. Nordic Council of MinistersOECD Report: Gender Equality Boosts GDP Growth in Nordic Region
  3. Centre Maurits Coppieters“Peace and reconciliation is a process that takes decades” Dr. Anthony Soares on #Brexit and Northern Ireland
  4. Mission of China to the EUMEPs Positive on China’s New Measures of Opening Up
  5. Macedonian Human Rights MovementOld White Men are Destroying Macedonia by Romanticizing Greece
  6. Counter BalanceControversial EIB-Backed Project Under Fire at European Parliament
  7. Nordic Council of MinistersIncome Inequality Increasing in Nordic Countries
  8. European Jewish CongressEU Leaders to Cease Contact with Mahmoud Abbas Until He Apologizes for Antisemitic Comments
  9. International Partnership for Human RightsAnnual Report celebrates organization’s tenth anniversary
  10. Nordic Council of MinistersNordic Cooperation Needed on Green Exports and Funding
  11. Mission of China to the EUPremier Li Confirms China Will Continue to Open Up
  12. European Jewish CongressCalls on Brussels University to Revoke Decision to Honour Ken Loach

Stakeholders' Highlights

  1. Sustainable Energy Week 2018"Lead the Clean Energy Transition"- Register and Join Us in Brussels from 5 to 7 May
  2. EU Green Week 2018Green Cities for a Greener Future. Join the Debate in Brussels from 22 to 24 May
  3. Nordic Council of Ministers12 Recommendations for Nordic Leadership on Climate and Environment
  4. Macedonian Human Rights MovementOxford Professor Calls for an End to the Anti-Macedonian Name Negotiations
  5. ACCAPeople Who Speak-Up Should Feel Safe to Do So
  6. Mission of China to the EUProgress on China-EU Cooperation
  7. Nordic Council of MinistersWorld's Energy Ministers to Meet in Oresund in May to Discuss Green Energy
  8. ILGA EuropeParabéns! Portugal Votes to Respect the Rights of Trans and Intersex People
  9. Mission of China to the EUJobs, Energy, Steel: Government Work Report Sets China's Targets
  10. European Jewish CongressKantor Center Annual Report on Antisemitism Worldwide - The Year the Mask Came Off
  11. UNICEFCalls for the Protection of Children in the Gaza Strip
  12. Mission of China to the EUForeign Minister Wang Yi Highlights Importance of China-EU Relations

Stakeholders' Highlights

  1. Nordic Council of MinistersImmigration and Integration in the Nordic Region - Getting the Facts Straight
  2. Macedonian Human Rights MovementMacedonians in Bulgaria Demand to End the Anti-Macedonian Name Negotiations
  3. Counter BalanceThe EIB Needs to Lead by Example on Tax Justice
  4. ILGA EuropeTrans People in Sweden to be Paid Compensation for Forced Sterilisation
  5. International Partnership for Human RightsThe Danger of Standing Up for Justice and Rights in Central Asia
  6. Mission of China to the EUChina and EU Must Work Together to Promote Global Steel Sector
  7. Swedish EnterprisesEU Tax Proposal on Digital Services Causes Concern for Small Exporting Economies
  8. European Jewish CongressCondemns the Horrific Murder of Holocaust Survivor Mireille Knoll in Paris
  9. Mission of China to the EUAn Open China Will Foster a World-Class Business Environment
  10. ECR GroupAn Opportunity to Help Shape a Better Future for Europe
  11. Counter BalanceControversial Turkish Azerbaijani Gas Pipeline Gets Major EU Loan
  12. World VisionSyria’s Children ‘At Risk of Never Fully Recovering', New Study Finds